Reports & Publications

Personalized Medicine Regulation Pathways for Oversight of Diagnostics
Personalized Medicine Coalition
February 2013

AACR Cancer Progress Report 2012
American Association for Cancer Research
September 2012

Sustaining Progress Against Cancer in an Era of Cost Containment
Turning the Tide Against Cancer Through Sustained Medical Innovation
June 2012

Recognizing Value in Oncology Innovation
Boston Healthcare Associates
June 2012

The Case for Personalized Medicine
Personalized Medicine Coalition
November 2011

AACR Cancer Progress Report 2011
American Association for Cancer Research
September 2011

A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer
Journal of the American Medical Association
May 2011

Whole-Genome Sequencing: A Step Closer to Personalized Medicine
Journal of the American Medical Association
April 2011

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
Nature Genetics
April 2011

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
Nature Genetics
April 2011

Many Doctors Know Little About Personalized Medicine But Are Eager to Learn, Study Finds
PMC Newsletter
Spring 2011

Early Accelerated Approval for Highly Targeted Cancer Drugs
New England Journal of Medicine
March 2011

Initial genome sequencing and analysis of multiple myeloma
Nature
March 2011

Adriana Jenkins - ‘A Dying Wish’
Forbes
February 2011

Enabling Personalized Medicine through Health Information Technology
Brookings Institute
January 2011

One In A Billion: A boy's life, a medical mystery
Milwaukee Journal Sentinel
December 2010

The Adverse Impact of the US Reimbursement System on the Development and Adoption of Personalized Medicine Diagnostics
Personalized Medicine Coalition
December 2010

Personalized Medicine Is Playing a Growing Role in Development Pipelines
Tufts Center for the Study of Drug Development Impact Report
November/December 2010

Federal Government Takes Steps to Advance Personalized Care
PMC Newsletter
Fall 2010

Melanoma — An Unlikely Poster Child for Personalized Cancer Therapy
New England Journal of Medicine
August 2010

Preparing for a Consumer-Driven Genomic Age
New England Journal of Medicine
August 2010

The Path to Personalized Medicine
New England Journal of Medicine
June 2010

Genomic Medicine – An Updated Primer
New England Journal of Medicine
May 2010

Ten Years On — The Human Genome and Medicine
New England Journal of Medicine
May 2010

Drug Regulation Must Evolve, FDA Official Says
PMC Newsletter
Spring 2010

The Human Genome at Ten
Nature feature issue
April 2010

Personalized Medicine Coalition Applauds New Health Care Reform Law
PMC Press Release
March 2010

NIH Director Dr. Francis Collins Interview on Personalized Medicine
The Diane Rehm Show, National Public Radio
March 2010

Policy Brief: Personalized Medicine’s Profile Grows in Washington
PMC Newsletter
Winter 2010

Comments to FDA of Companion Diagnostics
Personalized Medicine Coalition
December 2009

The New Science of Personalized Medicine: Translating the Promise into Practice
PricewaterhouseCoopers
December 2009

Comparative Effectiveness Research and Personalized Medicine: From Contradiction to Synergy
The Lewin Group (Prepared for: Personalized Medicine Coalition)
October 2009

21st Century Science: Comparative Effectiveness Research and Personalized Medicine
Personalized Medicine Coalition and National Pharmaceutical Council
October 2009

PMC Brings Personalized Medicine into Health Reform Debate
PMC Newsletter
Summer 2009

Decision Memo for Pharmacogenomic Testing for Warfarin Response
Centers for Medicare and Medicaid Services (CMS)
August 2009

Diagnostics 2009: Moving Towards Personalized Medicine
PricewaterhouseCoopers
July 2009

Initial National Priorities for Comparative Effectiveness Research
Institute of Medicine
June 2009

Obama’s Election Creates Opportunities, Challenges for Personalized Medicine
PMC Newsletter
Spring 2009

The Integration of Genetic Technologies Into Health Care and Public Health: A Progress Report and Future Directions of the Secretary's Advisory Committee on Genetics, Health, and Society
Secretary's Advisory Committee on Genetics, Health, and Society (SACGHS)
January 2009

Personalized Medicine and Healthcare Reform: Policy that Protects Innovation While Improving Value and Quality
Personalized Medicine Coalition
November 2008

Report Calls for Greater Federal Support of Personalized Medicine
PMC Newsletter
Fall 2008

Priorities for Personalized Medicine
President’s Council of Advisors on Science and Technology
September 2008

Realizing the Potential of Pharmacogenomics: Opportunities and Challenges
Secretary's Advisory Committee on Genetics, Health, and Society (SACGHS)
May 2008

U.S. System of Oversight of Genetic Testing: A Response to the Charge of the Secretary of Health and Human Services
Secretary’s Advisory Committee on Genetics, Health, and Society (SACGHS)
April 2008

Policy Issues Associated with Undertaking a New Large U.S. Population Cohort Study of Genes, Environment, and Disease
Secretary's Advisory Committee on Genetics, Health, and Society (SACGHS)
March 2007

Table of Valid Genomic Biomarkers in the Context of Approved Drug Labels
U.S. Food and Drug Administration